Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology Annual Meeting
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
Skyharbour's Partner North Shore Uranium Completes Prospecting Program at the Falcon Project; Significant Radioactivity Discovered in Outcrops and Boulders
CHARBONE Signs Five-Year Clean UHP Hydrogen Supply Agreement in Ontario, Marking a Major Milestone in its Commercial Expansion
CHARBONE signe une entente d'approvisionnement en hydrogene propre a UHP d'une duree de 5 ans en Ontario, marquant une etape majeure dans son expansion commerciale
